80 \u00fclkede faaliyet g\u00f6steren Japon \u0130la\u00e7 devi Takeda\u2019n\u0131n d\u00fcnya \u00e7ap\u0131ndaki \u00fcst d\u00fczey y\u00f6netim kadrosunda T\u00fcrk y\u00f6neticileri ile \u00f6ne \u00e7\u0131k\u0131yor.<\/p>\n
Son 10 y\u0131lda 30\u2019dan fazla T\u00fcrk liderin global \u00fcst d\u00fczey pozisyonlara atand\u0131\u011f\u0131 k\u00fcresel biyofarma \u015firketinde, Dr. Ahmet Melih K\u00fcre\u00e7, Hindistan Medikal ve Hasta Hizmetleri Direkt\u00f6r\u00fc olarak atand\u0131.<\/p>\n
Farkl\u0131 \u00fclkelerde sorumluluklar \u00fcstlenen, geni\u015f co\u011frafyalarda ekip y\u00f6neten ve stratejiye y\u00f6n veren T\u00fcrk liderler; Takeda\u2019n\u0131n kapsay\u0131c\u0131l\u0131k k\u00fclt\u00fcr\u00fcn\u00fcn \u00f6nemli temsilcileri aras\u0131nda yer al\u0131yor. Bu g\u00fc\u00e7l\u00fc temsilin son \u00f6rneklerinden biri de Takeda\u2019n\u0131n farkl\u0131 b\u00f6lgelerinde sorumluluklar \u00fcstlenen Dr. Ahmet Melih K\u00fcre\u00e7 oldu. Son 4 y\u0131ld\u0131r Takeda GEM B\u00f6lgesi (B\u00fcy\u00fcyen ve Geli\u015fen Pazarlardan) Onkoloji Medikal Lideri rol\u00fcn\u00fc y\u00fcr\u00fcten Dr. Ahmet Melih K\u00fcre\u00e7, 1 Aral\u0131k 2025 tarihi itibar\u0131yla Takeda Hindistan Medikal ve Hasta Hizmetleri Direkt\u00f6r\u00fc g\u00f6revine atand\u0131.<\/p>\n
\u0130la\u00e7 end\u00fcstrisinde 12 y\u0131l\u0131 a\u015fk\u0131n deneyime sahip olan Dr. Ahmet Melih K\u00fcre\u00e7, Bayer ve AstraZeneca gibi global \u015firketlerde edindi\u011fi deneyimlerin ard\u0131ndan 2017 y\u0131l\u0131nda Takeda T\u00fcrkiye\u2019ye Onkoloji Medikal M\u00fcd\u00fcr\u00fc olarak kat\u0131ld\u0131. 2017\u20132020 y\u0131llar\u0131 aras\u0131nda ICMEA B\u00f6lgesinde onkoloji projelerine liderlik ederken, 2020\u20132022 d\u00f6neminde T\u00fcrkiye ve ICMEA Nadir Genetik Hastal\u0131klar ve N\u00f6robilim Terapi Alan Lideri olarak hem yerel hem de b\u00f6lgesel stratejik \u00e7al\u0131\u015fmalara y\u00f6n verdi. 8 y\u0131ld\u0131r Takeda b\u00fcnyesinde farkl\u0131 tedavi alanlar\u0131nda ve \u00e7oklu co\u011frafyalarda (Rusya, Orta Do\u011fu, Latin Amerika, Asya-Pasifik) y\u00fcr\u00fctt\u00fc\u011f\u00fc \u00e7al\u0131\u015fmalarla b\u00f6lgesel ve global medikal stratejilerinin \u015fekillendirilmesine liderlik etti.<\/p>\n
Dr. K\u00fcre\u00e7, 1 Aral\u0131k 2025 tarihi itibar\u0131yla \u00fcstlenece\u011fi Takeda Hindistan Medikal ve Hasta Hizmetleri Direkt\u00f6rl\u00fc\u011f\u00fc g\u00f6revi kapsam\u0131nda \u015firketin Hindistan\u2019daki medikal stratejilerin \u015fekillenmesinde etkin rol alacak ve yeni rol\u00fcnde; tedavi alanlar\u0131na y\u00f6nelik bilimsel yol haritalar\u0131n\u0131n geli\u015ftirilmesi, medikal & saha ekiplerinin bilimsel yetkinliklerinin art\u0131r\u0131lmas\u0131, ger\u00e7ek ya\u015fam verisi ve kan\u0131t \u00fcretimi projelerinin yayg\u0131nla\u015ft\u0131r\u0131lmas\u0131, dijital sa\u011fl\u0131k uygulamalar\u0131n\u0131n g\u00fc\u00e7lendirilmesi ve s\u00fcrd\u00fcr\u00fclebilir hasta odakl\u0131 yakla\u015f\u0131m\u0131n \u00fclke genelinde benimsenmesi gibi sorumluluklar \u00fcstlenecek.<\/p>\n
T\u0131p e\u011fitimini \u0130stanbul \u00dcniversitesi Cerrahpa\u015fa T\u0131p Fak\u00fcltesi\u2019nde, y\u00fcksek lisans\u0131n\u0131 ise Bah\u00e7e\u015fehir \u00dcniversitesi\u2019nde tamamlayan Dr. K\u00fcre\u00e7; Oxford ve Harvard gibi \u00f6nemli \u00fcniversitelerde ileri d\u00fczey liderlik ve bilimsel e\u011fitim programlar\u0131na kat\u0131larak \u00e7ok y\u00f6nl\u00fc akademik ve y\u00f6netsel formasyonunu g\u00fc\u00e7lendirmi\u015ftir.<\/p>\n
\u00a0<\/p>\n
<\/strong> 80 \u00fclkede faaliyet g\u00f6steren Japon \u0130la\u00e7 devi Takeda\u2019n\u0131n d\u00fcnya \u00e7ap\u0131ndaki \u00fcst d\u00fczey y\u00f6netim kadrosunda T\u00fcrk y\u00f6neticileri ile \u00f6ne \u00e7\u0131k\u0131yor. Son 10 y\u0131lda 30\u2019dan fazla T\u00fcrk liderin global \u00fcst d\u00fczey pozisyonlara atand\u0131\u011f\u0131 k\u00fcresel biyofarma \u015firketinde, Dr. Ahmet Melih K\u00fcre\u00e7, Hindistan Medikal ve Hasta Hizmetleri Direkt\u00f6r\u00fc olarak atand\u0131.<\/p>\n","protected":false},"author":1,"featured_media":15447,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAow07ekDA:productID":"","footnotes":""},"categories":[4,10,11,13],"tags":[],"class_list":["post-15446","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dunya","category-otomobil","category-saglik","category-teknoloji"],"_links":{"self":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/15446","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=15446"}],"version-history":[{"count":0,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/15446\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/media\/15447"}],"wp:attachment":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=15446"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=15446"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=15446"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nSANAY\u0130 HABER AJANSI <\/p>\n","protected":false},"excerpt":{"rendered":"